An observational study in Fungal Malignant Otitis Externa, sponsored by Sohag University. Recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Sohag University · Observational
This prospective observational study aims to evaluate the diagnostic and therapeutic challenges of fungal malignant otitis externa in patients attending Sohag University Hospital. It will assess clinical presentation, diagnostic findings, treatment approaches, and clinical outcomes to improve understanding and management of this condition.
23 studies on the registry are indexed under Otitis Externa; 2 are open to participants now.
Browse Otitis Externa studies →Sohag University is the lead sponsor of 1,232 studies on the registry; 638 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients of any age or sex presenting to Sohag University Hospital with suspected or confirmed malignant otitis externa, who will be evaluated clinically and microbiologically to identify fungal pathogens and assess diagnostic and therapeutic challenges.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Microbiological culture of appropriate clinical specimens to identify bacterial and fungal pathogens. Further identification and susceptibility testing will be performed when applicable.
Number of participants with Clinical, Radiological, and Microbiological Findings in Patients with Fungal Malignant Otitis Externa
Clinical findings will be assessed by ENT clinical examination. Radiological findings will be assessed using CT and/or MRI. Microbiological findings will be assessed using bacterial and fungal cultures of ear discharge or tissue samples. Results will be reported as the number of patients (n, ) for each finding.
Time frame: Through study completion, an average of 1 year
Plan to share: Undecided
No publications or documents are linked to this record.
Started Oct 2026 (actual). Primary completion is estimated for Nov 2027, 13 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.